JNJ: Johnson & Johnson - Summary | Jitta

Johnson & Johnson

NYSE:JNJ

Price
$153.43
Loss Chance
43.3%
6.89JITTA SCORE
7.74%Over Jitta Line
Jitta Ranking
24 / 1,180
668 / 5,029
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (44)
Recent Business Performance (49)
Financial Strength (78)
Return to Shareholders (91)
Competitive Advantage (75)
Jitta Signs
Revenue and EarningConsistent
Operating MarginConsistent
Debt LevelLow Long Term Debt
Return on EquityConsistently High
Dividend PayoutIncreasing Every Year
CapExVery Low
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Recent Business PerformanceEarning decline 5.49% in the last year
Key Stats
Jitta Score
Jitta Line
6.89
7.74%
1.90
83.45%
1.96
187.51%
Pharmaceuticals
6.58
35.88%
2.84
95.89%
4.79
31.47%
COMPANY DESCRIPTION
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company’s Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.